335 related articles for article (PubMed ID: 32184779)
1. TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens.
Akatsuka Y
Front Immunol; 2020; 11():257. PubMed ID: 32184779
[TBL] [Abstract][Full Text] [Related]
2. Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy.
Zhu L; Yang X; Zhong D; Xie S; Shi W; Li Y; Hou X; HuaYao ; Zhou H; Zhao M; Ding Z; Zhao X; Mo F; Yin S; Liu A; Lu X
J Immunol Res; 2020; 2020():2454907. PubMed ID: 32964055
[TBL] [Abstract][Full Text] [Related]
3. The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments.
Chen T; Deng J; Zhang Y; Liu B; Liu R; Zhu Y; Zhou M; Lin Y; Xia B; Lin K; Ma X; Zhang H
Mol Cancer; 2024 Mar; 23(1):53. PubMed ID: 38468291
[TBL] [Abstract][Full Text] [Related]
4. Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4.
Alsalloum A; Shevchenko J; Fisher M; Philippova J; Perik-Zavodskii R; Perik-Zavodskaia O; Alrhmoun S; Lopatnikova J; Vasily K; Volynets M; Zavjalov E; Solovjeva O; Akahori Y; Shiku H; Silkov A; Sennikov S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894816
[TBL] [Abstract][Full Text] [Related]
5. Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.
Nicholls S; Piper KP; Mohammed F; Dafforn TR; Tenzer S; Salim M; Mahendra P; Craddock C; van Endert P; Schild H; Cobbold M; Engelhard VH; Moss PA; Willcox BE
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3889-94. PubMed ID: 19234124
[TBL] [Abstract][Full Text] [Related]
6. A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7.
Poorebrahim M; Quiros-Fernandez I; Marmé F; Burdach SE; Cid-Arregui A
Cancer Lett; 2023 Jul; 566():216242. PubMed ID: 37217069
[TBL] [Abstract][Full Text] [Related]
7. Who wins the combat, CAR or TCR?
Yun K; Siegler EL; Kenderian SS
Leukemia; 2023 Oct; 37(10):1953-1962. PubMed ID: 37626090
[TBL] [Abstract][Full Text] [Related]
8. Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor T Cells: The Intersection of Stem Cells and Immunotherapy.
Lahimchi MR; Maroufi F; Maali A
Cell Reprogram; 2023 Oct; 25(5):195-211. PubMed ID: 37782910
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4
Wang L; Matsumoto M; Akahori Y; Seo N; Shirakura K; Kato T; Katsumoto Y; Miyahara Y; Shiku H
Mol Ther; 2024 Mar; 32(3):734-748. PubMed ID: 38243600
[TBL] [Abstract][Full Text] [Related]
10. T cell engineering for adoptive T cell therapy: safety and receptor avidity.
D'Ippolito E; Schober K; Nauerth M; Busch DH
Cancer Immunol Immunother; 2019 Oct; 68(10):1701-1712. PubMed ID: 31542797
[TBL] [Abstract][Full Text] [Related]
11. TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential.
Poorebrahim M; Mohammadkhani N; Mahmoudi R; Gholizadeh M; Fakhr E; Cid-Arregui A
Cancer Gene Ther; 2021 Jun; 28(6):581-589. PubMed ID: 33654227
[TBL] [Abstract][Full Text] [Related]
12. Imaging CAR-T Synapse as a Quality Control for CAR Engineering.
Xiao Q; Su X
Methods Mol Biol; 2023; 2654():503-512. PubMed ID: 37106204
[TBL] [Abstract][Full Text] [Related]
13. Needle in a Haystack: The Naïve Repertoire as a Source of T Cell Receptors for Adoptive Therapy with Engineered T Cells.
D'Ippolito E; Wagner KI; Busch DH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171940
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside-Functionalized Nanoparticles for Chimeric Antigen Receptor T-Cell Activation at the Immunological Synapse.
Zang H; Siddiqui M; Gummuluru S; Wong WW; Reinhard BM
ACS Nano; 2022 Nov; 16(11):18408-18420. PubMed ID: 36282488
[TBL] [Abstract][Full Text] [Related]
15. Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics.
Cheng J; Zhao Y; Hu H; Tang L; Zeng Y; Deng X; Ding S; Guo AY; Li Q; Zhu X
Cancer Immunol Immunother; 2023 Oct; 72(10):3163-3174. PubMed ID: 37382633
[TBL] [Abstract][Full Text] [Related]
16. Charging CAR by electrostatic power.
Wang H; Huang Y; Xu C
Immunol Rev; 2023 Nov; 320(1):138-146. PubMed ID: 37366589
[TBL] [Abstract][Full Text] [Related]
17. Mechanical force determines chimeric antigen receptor microclustering and signaling.
Qiu Y; Xiao Q; Wang Y; Cao Y; Wang J; Wan Z; Chen X; Liu W; Ma L; Xu C
Mol Ther; 2024 Apr; 32(4):1016-1032. PubMed ID: 38327049
[TBL] [Abstract][Full Text] [Related]
18. Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells.
Takayanagi SI; Wang B; Hasegawa S; Nishikawa S; Fukumoto K; Nakano K; Chuganji S; Kato Y; Kamibayashi S; Minagawa A; Kunisato A; Nozawa H; Kaneko S
Mol Ther Methods Clin Dev; 2023 Dec; 31():101109. PubMed ID: 37822720
[TBL] [Abstract][Full Text] [Related]
19. [T cell receptor-based immunotherapy: a review].
Chen Y; Gao GF; Tan S
Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):4004-4028. PubMed ID: 37877387
[TBL] [Abstract][Full Text] [Related]
20. Hyperstabilization of T cell microvilli contacts by chimeric antigen receptors.
Beppler C; Eichorst J; Marchuk K; Cai E; Castellanos CA; Sriram V; Roybal KT; Krummel MF
J Cell Biol; 2023 Mar; 222(3):. PubMed ID: 36520493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
